Clinical value of adding Dapagliflozin in patients with nephrotic syndrome.

MLA

ElSharkawy, Magdy, et al. “Clinical Value of Adding Dapagliflozin in Patients with Nephrotic Syndrome.” International Urology & Nephrology, vol. 56, no. 11, Nov. 2024, pp. 3617–25. EBSCOhost, https://doi.org/10.1007/s11255-024-04099-1.

APA

ElSharkawy, M., Emara, A., Ahmed, M. M., Ghonamy, E., & Teama, N. M. (2024). Clinical value of adding Dapagliflozin in patients with nephrotic syndrome. International Urology & Nephrology, 56(11), 3617–3625. https://doi.org/10.1007/s11255-024-04099-1

Chicago

ElSharkawy, Magdy, Ahmed Emara, Mohamed Mohyeldin Ahmed, ElSayed Ghonamy, and Nahla Mohamed Teama. 2024. “Clinical Value of Adding Dapagliflozin in Patients with Nephrotic Syndrome.” International Urology & Nephrology 56 (11): 3617–25. doi:10.1007/s11255-024-04099-1.